Sterling Biotech and Zydus Lifesciences agree to extend completion of business transfer
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
Zydus Lifesciences and SBL have mutually decided to extend the date of closing upto March 31, 2025
Puri is an accomplished leader and financial sector veteran with over four decades of experience
Alankit will undertake the verification of pending e-KYC enrollments through the Beneficiary Identification System (BIS) platform provided by the National Health Authority (NHA).
Initiative aimed at enhancing workforce skills and competency in line with industry standards so as to create a talented workforce for the Fourth Industrial Revolution
This facility is considered to be in a minimally acceptable state of compliance with regard to current GMP
The transaction is expected to result in approximately $175 million to support further development of IMG-007
Exploring new opportunities within the fast-growing market of microfluidics
The company has received the GMP Certification after successful closure of the inspection
FDC Ltd has received final approval from USFDA for the company's Abbreviated New Drug Application (ANDA) for Cefixime 400 mg Tablets
Subscribe To Our Newsletter & Stay Updated